Atrial Fibrillation Trial, Recruiting NCT06436924 Sponsor: Heart Rhythm Clinical and Research Solutions, LLC Condition: Atrial Fibrillation
Back to Atrial Fibrillation

Atrial Fibrillation Trial, Recruiting

NCT06436924
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older
  • People who are able and willing to attend all study visits and check-ins for the full duration of the study
  • People who a doctor (the study investigator) has determined are medically appropriate to receive a left atrial appendage closure (LAAO) device
  • People who are already scheduled to receive a specific LAAO device called a Watchman FLX™ or Watchman FLX Pro™ as part of their regular medical care
  • People whose LAAO device procedure is scheduled on a day when the implanting doctor has 8 or more of these procedures planned, as confirmed within 2 days before the procedure date
  • People who are willing and able to give their informed consent to participate

Who may not be able to join:

  • People who are already enrolled in another clinical trial for an investigational drug or device, or any trial that controls their treatment plan
  • People who, in the opinion of the study doctor, have a known medical reason that would make receiving an LAAO device or the related procedure unsafe or unsuitable for them
  • People whose procedure is scheduled on a day when the implanting doctor has fewer than 8 LAAO device procedures planned, as confirmed within 2 days before the procedure date

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Saumil Oza, MD, St. Vincent's

Phone: 615-448-5770

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Heart Rhythm Clinical and Research Solutions, LLC
Registry
ClinicalTrials.gov
Start date
14 May 2024
Est. completion
30 December 2025

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Peri-procedural complications; Peri-device leakage; Late onset complications

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov